
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.cc84172e9e16.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.b634933a977d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.913c7dcab8ff.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939BE807DB0F4BC500003F89F041A767.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="0.0" />

<meta name="ncbi_domain" content="intjoncol" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC3834873/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834873/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="International Journal of Oncology" /><meta name="citation_title" content="Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells" /><meta name="citation_author" content="KATHRIN ZITZMANN" /><meta name="citation_author_institution" content="Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, Germany" /><meta name="citation_author" content="GALINA AILER" /><meta name="citation_author_institution" content="Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, Germany" /><meta name="citation_author" content="GEORGE VLOTIDES" /><meta name="citation_author_institution" content="Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, Germany" /><meta name="citation_author" content="GERALD SPOETTL" /><meta name="citation_author_institution" content="Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, Germany" /><meta name="citation_author" content="JULIAN MAURER" /><meta name="citation_author_institution" content="Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, Germany" /><meta name="citation_author" content="BURKHARD G&#x000d6;KE" /><meta name="citation_author_institution" content="Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, Germany" /><meta name="citation_author" content="FELIX BEUSCHLEIN" /><meta name="citation_author_institution" content="Department of Internal Medicine IV Campus Innenstadt, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, Germany" /><meta name="citation_author" content="CHRISTOPH J. AUERNHAMMER" /><meta name="citation_author_institution" content="Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, Germany" /><meta name="citation_publication_date" content="2013/12" /><meta name="citation_issue" content="6" /><meta name="citation_volume" content="43" /><meta name="citation_firstpage" content="1824" /><meta name="citation_doi" content="10.3892/ijo.2013.2130" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3834873/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC3834873/" /><meta name="citation_pmid" content="24100469" /><meta name="DC.Title" content="Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Spandidos Publications" /><meta name="DC.Contributor" content="KATHRIN ZITZMANN" /><meta name="DC.Contributor" content="GALINA AILER" /><meta name="DC.Contributor" content="GEORGE VLOTIDES" /><meta name="DC.Contributor" content="GERALD SPOETTL" /><meta name="DC.Contributor" content="JULIAN MAURER" /><meta name="DC.Contributor" content="BURKHARD G&#x000d6;KE" /><meta name="DC.Contributor" content="FELIX BEUSCHLEIN" /><meta name="DC.Contributor" content="CHRISTOPH J. AUERNHAMMER" /><meta name="DC.Date" content="2013 Dec" /><meta name="DC.Identifier" content="10.3892/ijo.2013.2130" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells" /><meta property="og:type" content="article" /><meta property="og:description" content="The heat shock protein (HSP) 90 chaperone machine involved in numerous oncogenic signaling pathways is over-expressed in cancer cells and is currently being evaluated for anticancer therapy. Neuroendocrine tumors (NETs) of the gastroenteropancreatic (GEP) ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834873/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    


    
        

<section class="pmc-alerts">
    
    <div role="alert" class="pmc-alert pmc-alert--info" role="region" aria-label="Alert" aria-hidden="false"  data-key="pmc-alert-welcome">
        <div class="pmc-alert__body pmc-alert--ncbi-icon">
            <div class="pmc-alert__content">
                <p>
                    <strong>
                        Preview improvements coming to the PMC website in October 2024.
                        <a href="https://ncbiinsights.ncbi.nlm.nih.gov/2024/03/14/preview-pmc-improvements/" data-ga-category="cloud_beta_banner" data-ga-label="learn_more" data-ga-action="on_pmc2020">Learn More</a> or
                        <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3834873/" data-ga-category="cloud_beta_banner" data-ga-action="on_pmc2020" data-ga-label="go_to_cloud">Try it out now</a>.
                    </strong>
                </p>
            </div>
        </div>
    </div>
    
</section>
    

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Int J Oncol%22[journal]" class="navlink">Int J Oncol</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3834873
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3834873/pdf/ijo-43-06-1824.pdf" class="int-view">PDF (1.0M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3834873/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3834873/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3834873" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3834873%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="YmRLdIdF9fbEmuo8hxuvWEhBO6tQfOY2ao8clwEGRfOwdmEYvrEDN74hk91IqvJl">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3834873%2F&amp;text=Potent%20antitumor%20activity%20of%20the%20novel%20HSP90%20inhibitors%20AUY922%20and%20HSP990%20in%20neuroendocrine%20carcinoid%20cells" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3834873%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834873/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3834873/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/24100469/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3834873/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/24100469/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3834873/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3834873/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/?term=%22Int J Oncol%22[journal]" class="navlink">Int J Oncol</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC3834873
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-intjoncol.gif" alt="Logo of intjoncol" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.spandidos-publications.com/ijo" target="_blank" rel="noopener noreferrer" ref="reftype=publisher&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">Int J Oncol.</span> 2013 Dec; 43(6): 1824–1832. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2013 Oct 4. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.3892%2Fijo.2013.2130" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.3892/ijo.2013.2130</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3834873</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/24100469">24100469</a></div></div></div><h1 class="content-title">Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=ZITZMANN%20K%5BAuthor%5D" class="affpopup" co-rid="_co_idm140547752798480" co-class="co-affbox">KATHRIN ZITZMANN</a>,<sup>1,</sup><sup>*</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=AILER%20G%5BAuthor%5D" class="affpopup" co-rid="_co_idm140547752796624" co-class="co-affbox">GALINA AILER</a>,<sup>1,</sup><sup>*</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=VLOTIDES%20G%5BAuthor%5D" class="affpopup" co-rid="_co_idm140547746318816" co-class="co-affbox">GEORGE VLOTIDES</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=SPOETTL%20G%5BAuthor%5D" class="affpopup" co-rid="_co_idm140547753133024" co-class="co-affbox">GERALD SPOETTL</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=MAURER%20J%5BAuthor%5D" class="affpopup" co-rid="_co_idm140547755165712" co-class="co-affbox">JULIAN MAURER</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=G&#x000d6;KE%20B%5BAuthor%5D" class="affpopup" co-rid="_co_idm140547748506000" co-class="co-affbox">BURKHARD G&#x000d6;KE</a>,<sup>1</sup> <a href="https://pubmed.ncbi.nlm.nih.gov/?term=BEUSCHLEIN%20F%5BAuthor%5D" class="affpopup" co-rid="_co_idm140547748503888" co-class="co-affbox">FELIX BEUSCHLEIN</a>,<sup>2</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=AUERNHAMMER%20CJ%5BAuthor%5D" class="affpopup" co-rid="_co_idm140547760169760" co-class="co-affbox">CHRISTOPH J. AUERNHAMMER</a><sup>1</sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140547752798480"><h3 class="no_margin">KATHRIN ZITZMANN</h3><p><sup>1</sup>Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, 
Germany</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=ZITZMANN%20K%5BAuthor%5D">KATHRIN ZITZMANN</a></div></div><div id="_co_idm140547752796624"><h3 class="no_margin">GALINA AILER</h3><p><sup>1</sup>Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, 
Germany</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=AILER%20G%5BAuthor%5D">GALINA AILER</a></div></div><div id="_co_idm140547746318816"><h3 class="no_margin">GEORGE VLOTIDES</h3><p><sup>1</sup>Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, 
Germany</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=VLOTIDES%20G%5BAuthor%5D">GEORGE VLOTIDES</a></div></div><div id="_co_idm140547753133024"><h3 class="no_margin">GERALD SPOETTL</h3><p><sup>1</sup>Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, 
Germany</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=SPOETTL%20G%5BAuthor%5D">GERALD SPOETTL</a></div></div><div id="_co_idm140547755165712"><h3 class="no_margin">JULIAN MAURER</h3><p><sup>1</sup>Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, 
Germany</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=MAURER%20J%5BAuthor%5D">JULIAN MAURER</a></div></div><div id="_co_idm140547748506000"><h3 class="no_margin">BURKHARD G&#x000d6;KE</h3><p><sup>1</sup>Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, 
Germany</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=G&#x000d6;KE%20B%5BAuthor%5D">BURKHARD G&#x000d6;KE</a></div></div><div id="_co_idm140547748503888"><h3 class="no_margin">FELIX BEUSCHLEIN</h3><p><sup>2</sup>Department of Internal Medicine IV Campus Innenstadt, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, 
Germany</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=BEUSCHLEIN%20F%5BAuthor%5D">FELIX BEUSCHLEIN</a></div></div><div id="_co_idm140547760169760"><h3 class="no_margin">CHRISTOPH J. AUERNHAMMER</h3><p><sup>1</sup>Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, 
Germany</p><div>Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=AUERNHAMMER%20CJ%5BAuthor%5D">CHRISTOPH J. AUERNHAMMER</a></div></div></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm140547757810368_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140547757810368_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140547757810368_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm140547757810368_ai" style="display:none"><div class="fm-affl" id="af1-ijo-43-06-1824"><sup>1</sup>Department of Internal Medicine II Campus Grosshadern, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, 
Germany</div><div class="fm-affl" id="af2-ijo-43-06-1824"><sup>2</sup>Department of Internal Medicine IV Campus Innenstadt, University-Hospital, Ludwig-Maximilians-University of Munich, D-81377 Munich, 
Germany</div><div id="c1-ijo-43-06-1824">Correspondence to: Dr Christoph J. Auernhammer, Department of Internal Medicine II, University-Hospital Campus Grosshadern, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEntero Pancreatic System, Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, D-81377 Munich, Germany, E-mail: <a href="mailto:dev@null" data-email="ed.nehcneum-inu.dem@remmahnreua.hpotsirhc" class="oemail">ed.nehcneum-inu.dem@remmahnreua.hpotsirhc</a></div><div id="fn1-ijo-43-06-1824"><sup>*</sup>Contributed equally</div></div><div class="fm-article-notes hide half_rhythm" id="idm140547757810368_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2013 Jul 12; Accepted 2013 Aug 26.</div></div><div class="permissions half_rhythm hide" id="idm140547757810368_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2013, Spandidos Publications</div><div class="license half_rhythm">This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="abstract-a.k.b.s" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abstract-a.k.b.stitle">Abstract</h2><!--article-meta--><div><p class="p p-first-last">The heat shock protein (HSP) 90 chaperone machine involved in numerous oncogenic signaling pathways is over-expressed in cancer cells and is currently being evaluated for anticancer therapy. Neuroendocrine tumors (NETs) of the gastroenteropancreatic (GEP) system comprise a heterogeneous group of tumors with increasing incidence and poor prognosis. Here, we report the antiproliferative effects of the HSP90 inhibitors AUY922 and HSP990 in neuroendocrine tumor cells. Treatment of human pancreatic BON1, bronchopulmonary NCI-H727 and midgut carcinoid GOT1 neuroendocrine tumor cells with increasing concentrations of AUY922 and HSP990 dose-dependently suppressed cell viability. Significant effects on neuroendocrine cell viability were observed with inhibitor concentrations as low as 5 nM. Inhibition of cell viability was associated with the induction of apoptosis as demonstrated by an increase in sub-G1 events and PARP cleavage. HSP90 inhibition was associated with decreased neuroendocrine ErbB and IGF-I receptor expression, decreased Erk and Akt phosphorylation and the induction of HSP70 expression. These findings provide evidence that targeted inhibition of upregulated HSP90 activity could be useful for the treatment of aggressive neuroendocrine tumors resistant to conventional therapy.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">heat shock protein 90, heat shock protein 90 inhibitors, gastroenteropancreatic, neuroendocrine tumor</span></div></div><div id="sec-a.l.a" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.l.atitle">Introduction</h2><p class="p p-first">Heat shock protein 90 (HSP90) is a molecular chaperone, which in complex with co-chaperones (such as HSP70) forms the HSP90 chaperone machine. This complex has been demonstrated to play an important role in stabilization and activation of numerous key oncogenic client proteins including Akt, MEK, EGFR, ErbB2 and IGF-IR (<a href="#b1-ijo-43-06-1824" rid="b1-ijo-43-06-1824" class=" bibr popnode">1</a>,<a href="#b2-ijo-43-06-1824" rid="b2-ijo-43-06-1824" class=" bibr popnode">2</a>). The HSP90 monomer consists of 3 domains: the amino terminal domain, which contains the ATP-binding site, the middle domain with docking sites for client proteins and the carboxy terminal region, which resembles a dimerization motif (<a href="#b2-ijo-43-06-1824" rid="b2-ijo-43-06-1824" class=" bibr popnode">2</a>). Co-chaperone binding sites are present in all 3 domains whereas drug-binding regions are present in the amino and carboxy terminal domains (<a href="#b2-ijo-43-06-1824" rid="b2-ijo-43-06-1824" class=" bibr popnode">2</a>). Normal chaperone function requires dimerization of two HSP90 monomers and recruitment of co-chaperones which regulate the conformational dynamics and activity of the chaperone (<a href="#b2-ijo-43-06-1824" rid="b2-ijo-43-06-1824" class=" bibr popnode">2</a>). HSP90 is over-expressed in cancer cells and associated with decreased survival in breast cancer, gastrointestinal stromal tumors and non-small cell lung cancer (<a href="#b3-ijo-43-06-1824" rid="b3-ijo-43-06-1824" class=" bibr popnode">3</a>). Given the potential to block multiple oncogenic signaling pathways simultaneously and thus possibly counteract escape mechanisms and resistance to targeted monotherapies, several HSP90 inhibitors are currently undergoing clinical trials in multiple indications as single agents or in combination therapy (<a href="#b2-ijo-43-06-1824" rid="b2-ijo-43-06-1824" class=" bibr popnode">2</a>&#x02013;<a href="#b4-ijo-43-06-1824" rid="b4-ijo-43-06-1824" class=" bibr popnode">4</a>).</p><p>Neuroendocrine tumors (NETs) of the gastroenteropancreatic (GEP) system comprise a rare group of tumors which accounts for &#x0223c;2% of all gastrointestinal tumors (<a href="#b5-ijo-43-06-1824" rid="b5-ijo-43-06-1824" class=" bibr popnode">5</a>,<a href="#b6-ijo-43-06-1824" rid="b6-ijo-43-06-1824" class=" bibr popnode">6</a>). Over the last decades the incidence of GEP NETs has increased considerably (<a href="#b6-ijo-43-06-1824" rid="b6-ijo-43-06-1824" class=" bibr popnode">6</a>,<a href="#b7-ijo-43-06-1824" rid="b7-ijo-43-06-1824" class=" bibr popnode">7</a>). Around 25% of all NETs present with distant metastasis at the time of first diagnosis and despite advances in surgical and medical therapy the overall 5-year survival rate remains rather low (&#x0223c;60%) (<a href="#b6-ijo-43-06-1824" rid="b6-ijo-43-06-1824" class=" bibr popnode">6</a>,<a href="#b8-ijo-43-06-1824" rid="b8-ijo-43-06-1824" class=" bibr popnode">8</a>,<a href="#b9-ijo-43-06-1824" rid="b9-ijo-43-06-1824" class=" bibr popnode">9</a>). Thus, novel therapeutic tools are needed for this heterogeneous group of tumors. Due to high activity of Akt and Erk signaling in NETs and compensatory activation of Akt in response to mTOR and Raf inhibitors, targeting HSP90 could provide a tool to simultaneously suppress both survival pathways (<a href="#b10-ijo-43-06-1824" rid="b10-ijo-43-06-1824" class=" bibr popnode">10</a>,<a href="#b11-ijo-43-06-1824" rid="b11-ijo-43-06-1824" class=" bibr popnode">11</a>). Furthermore, HSP90 overexpression has recently been reported in NETs and the HSP90 inhibitors 17-AAG and IPI-504 have demonstrated antiproliferative efficacy in several NET cell lines <em>in vitro</em> (<a href="#b12-ijo-43-06-1824" rid="b12-ijo-43-06-1824" class=" bibr popnode">12</a>,<a href="#b13-ijo-43-06-1824" rid="b13-ijo-43-06-1824" class=" bibr popnode">13</a>).</p><p class="p p-last">Here we report antiproliferative effects of the novel small molecule HSP90 inhibitors AUY922 and HSP990 and characterize HSP90 downstream signaling in neuroendocrine tumor cells of pancreatic, midgut and bronchopulmonary origin.</p></div><div id="sec-a.l.b" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.l.btitle">Materials and methods</h2><div id="sec-a.l.b.b" class="sec sec-first"><h3 id="sec-a.l.b.btitle">Materials</h3><p class="p p-first-last">DMEM/F12 media, penicillin and streptomycin were purchased from Gibco/Invitrogen (Karlsruhe, Germany) and RPMI medium was from PAA Laboratories (Pasching, Austria). Fetal bovine serum (FBS) and amphotericin B were from Biochrom (Berlin, Germany), and AUY922 and HSP990 were kindly provided from Novartis Pharma (Basel, Switzerland).</p></div><div id="sec-a.l.b.c" class="sec"><h3 id="sec-a.l.b.ctitle">Cell cultures</h3><p class="p p-first-last">All human neuroendocrine cell lines were received and cultured as described (<a href="#b14-ijo-43-06-1824" rid="b14-ijo-43-06-1824" class=" bibr popnode">14</a>). Briefly, pancreatic neuroendocrine BON1 tumor cells (kindly provided by R. G&#x000f6;ke, Marburg) were cultured in DMEM/F12 (1:1) medium supplemented with 10% FBS, 1% penicillin/streptomycin and 0.4% amphotericin B. Human midgut carcinoid GOT1 cells (kindly provided by Professor Ola Nilsson, Sahlgrenska University Hospital, Gothenburg, Sweden) and human broncho-pulmonary neuroendocrine NCI-H727 tumor cells (purchased from ATCC, Manassas, VA, USA) were both cultured in RPMI medium supplemented with 10% FBS, 1% penicillin/streptomycin and 0.4% amphotericin B. Additional supplements in GOT1 culture medium were 0.135 IU/ml insulin and 5 mg/dl apo-transferrin.</p></div><div id="sec-a.l.b.d" class="sec"><h3 id="sec-a.l.b.dtitle">Assessment of cell viability</h3><p class="p p-first-last">Cell viability was assessed as described (<a href="#b14-ijo-43-06-1824" rid="b14-ijo-43-06-1824" class=" bibr popnode">14</a>). Briefly, cells were seeded into 96-well plates at densities of 3,000 (BON1), 50,000 (GOT1) and 4,000 (NCIH727) cells per well, respectively, and grown for 24 h. The next day, medium was replaced by serum rich medium (10% FBS) containing various concentrations of AUY922 and HSP990 (0.1, 0.5, 1, 5, 10, 50, 100 nM) and the cells were further incubated for indicated time intervals. Cell viability expressed by metabolic activity was measured with Cell Titer 96 aqueous One Solution Cell Proliferation assay (Promega, Madison, WI, USA) according to the manufacturer&#x02019;s instructions. Following 3 h of incubation with Cell Titer 96 solution, absorbance at 492 nm was determined using an ELISA plate reader.</p></div><div id="sec-a.l.b.e" class="sec"><h3 id="sec-a.l.b.etitle">SYBR-DNA-labeling assay</h3><p class="p p-first-last">The SYBR-DNA-labeling experiment was performed identically to that described for the Cell Titer 96 aqueous One Solution Cell Proliferation assay. Assays were stopped after indicated time intervals by flicking off the medium and freezing the plate. Cells were stained with 200 <em>&#x003bc;</em>l/well of SYBR-Green<sup>&#x000ae;</sup> I (Lonza, Basel, Switzerland) 1:4,000 in <em>aqua destillata</em> for 30 min in the dark and then quantified by flourimetry at 530 nm with 485 nm excitation, measured using a CytoFluor<sup>&#x000ae;</sup> Multi-Well Plate Reader Series 4000 (PerSeptive Biosystems, Framingham, MA, USA).</p></div><div id="sec-a.l.b.f" class="sec"><h3 id="sec-a.l.b.ftitle">Cell cycle analysis</h3><p class="p p-first-last">Apoptosis and cell cycle distribution were analyzed using flow cytometry as described (<a href="#b14-ijo-43-06-1824" rid="b14-ijo-43-06-1824" class=" bibr popnode">14</a>). Briefly, cells were scraped with a rubber policeman, washed with PBS and incubated in staining buffer containing 0.1% sodium citrate, 0.1% Triton X-100 (Sigma) and 50 <em>&#x003bc;</em>g/ml propidium iodide overnight. Sub-G1 events and cell cycle distribution were measured in a fluorescence-activated cell sorter (FACSCalibur, Becton-Dickinson, Franklin Lakes, NJ, USA). Nuclei to the left of the G1-peak containing hypodiploid DNA were considered apoptotic.</p></div><div id="sec-a.l.b.g" class="sec"><h3 id="sec-a.l.b.gtitle">Caspase assay</h3><p class="p p-first-last">Activity of effector caspases 3 and 7 was measured with Caspase-Glo 3/7 assay (Promega) according to the manufacturer&#x02019;s instructions. Following 1 h of incubation with Caspase-Glo 3/7 reagent, luminescence was determined using a plate-reading luminometer.</p></div><div id="sec-a.l.b.h" class="sec"><h3 id="sec-a.l.b.htitle">Protein extraction and western blot analysis</h3><p class="p p-first-last">Protein extraction and western blot analysis were performed as described (<a href="#b14-ijo-43-06-1824" rid="b14-ijo-43-06-1824" class=" bibr popnode">14</a>). Briefly, cells were lysed in 500 <em>&#x003bc;</em>l lysis buffer. The lysates were centrifuged for 10 min at 4&#x000b0;C and 13,000 &#x000d7; g and supernatans were adjusted to equal protein loads and diluted 1:1 with SDS sample buffer. Samples were boiled for 5 min and separated on an SDS polyacrylamide gel. Proteins were electrotransferred for 60 min onto PVDF membranes (Immobilone; Millipore, Eschborn, Germany) using a semi-dry western blot technique. After blocking in 2% non-fat dried milk, the membranes were incubated overnight in appropriate dilutions of antibodies against pAkt (Ser 473) (1:20,000), Akt (1:5,000), pErk 1/2 (1:10,000), Erk 1/2 (1:20,000), PARP (1:1,000), IGFR (1:5,000), p70S6K (1:1,000), pp70S6K (1:2,000), 4EBP1 (1:2,000) p4EBP1 (1:1,000) (all from Cell Signaling, Danvers, MA, USA), HSP70 (1:10,000) (Biomol Stressgen, Hamburg, Germany), HSP90 (1:5,000), EGFR (1:1,000), ErbB2 (1:500), ErbB3 (1:1,000) and STAT3 (1:10,000) (all from Santa Cruz, Heidelberg, Germany). After washing with PBS, the membranes were incubated with peroxidise-conjugated secondary antibody (1:25,000) for 2 h. The blots were washed and immersed in the chemiluminescent substrate SuperSignal West Dura (Thermo Scientific, Rockford, IL, USA) and exposed to Super RX Fujifilm (Fujifilm Corporation, Tokyo, Japan).</p></div><div id="sec-a.l.b.i" class="sec sec-last"><h3 id="sec-a.l.b.ititle">Statistical analysis</h3><p class="p p-first-last">IC<sub>50</sub> inhibition values were determined with the use of Prism 6 for May OS X software (<a href="http://www.graphpad.com" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.graphpad.com</a>). Cell cycle phases were analyzed by Cell Quest Software (Becton-Dickinson) and comparisons evaluated using 2-tailed Student&#x02019;s t-test. Results are expressed as mean &#x000b1; SD of independently performed experiments. Statistical significance was set at p&#x0003c;0.05.</p></div></div><div id="sec-a.l.c" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.l.ctitle">Results</h2><div id="sec-a.l.c.b" class="sec sec-first"><h3 id="sec-a.l.c.btitle">HSP90 expression and inhibitor specificity</h3><p class="p p-first-last">Western blot analysis revealed BON1, NCI-H727 and GOT1 cells to express easily detectable levels of HSP90, while HSP70 was poorly expressed under baseline conditions. As increased HSP70 expression is a hallmark of specific HSP90 inhibition, we analyzed HSP70 expression after treatment with the HSP90 inhibitors AUY922 and HSP990. Treatment with increasing concentrations (10&#x02013;100 nM) of both inhibitors induced HSP70 expression in a dose-dependent manner (<a href="/pmc/articles/PMC3834873/figure/f1-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f1-ijo-43-06-1824" rid-ob="ob-f1-ijo-43-06-1824" co-legend-rid="lgnd_f1-ijo-43-06-1824"><span>Fig. 1</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f1-ijo-43-06-1824" co-legend-rid="lgnd_f1-ijo-43-06-1824"><a href="/pmc/articles/PMC3834873/figure/f1-ijo-43-06-1824/" target="figure" rid-figpopup="f1-ijo-43-06-1824" rid-ob="ob-f1-ijo-43-06-1824"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140547756048624"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3834873_IJO-43-06-1824-g00.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-43-06-1824-g00.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3834873/bin/IJO-43-06-1824-g00.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140547756048624"><a target="object" rel="noopener" href="/pmc/articles/PMC3834873/figure/f1-ijo-43-06-1824/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f1-ijo-43-06-1824"><div><a class="figpopup" href="/pmc/articles/PMC3834873/figure/f1-ijo-43-06-1824/" target="figure" rid-figpopup="f1-ijo-43-06-1824" rid-ob="ob-f1-ijo-43-06-1824">Figure 1.</a></div><!--caption a7--><div class="caption"><p>Induction of HSP70 expression by HSP90 inhibition in neuroendocrine tumor cells. BON1, NCI-H727 and GOT1 cells were treated with increasing concentrations (1&#x02013;100 nM) of the HSP90 inhibitors (A) AUY922 and (B) HSP990 for 2 and 24 h. Subsequently the expression of HSP90 and HSP70 was evaluated by western blot analysis. A representative blot of 3 independently performed experiments is shown.</p></div></div></div></div><div id="sec-a.l.c.c" class="sec"><h3 id="sec-a.l.c.ctitle">Inhibition of neuroendocrine cell viability by HSP90 inhibitors</h3><p class="p p-first">Treatment of human pancreatic neuroendocrine BON1 tumor cells with the HSP90 inhibitor AUY922 dose-dependently suppressed cell viability as assessed by measurement of metabolic activity and DNA content (<a href="/pmc/articles/PMC3834873/figure/f2-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-ijo-43-06-1824" rid-ob="ob-f2-ijo-43-06-1824" co-legend-rid="lgnd_f2-ijo-43-06-1824"><span>Fig. 2A, left panel</span></a>). Significant effects were observed at all time points tested (24, 72 and 144 h) beginning at AUY922 concentrations as low as 5 nM (suppression of metabolic activity to &#x0223c;89, 42 and 36% compared to non-treated controls, respectively; p&#x0003c;0.05) and peaked at the highest dose tested (100 nM; suppression of metabolic activity to &#x0223c;75, 17 and 1%, respectively; p&#x0003c;0.05). Similar to AUY922, the HSP90 inhibitor HSP990 also suppressed BON1 cell viability (<a href="/pmc/articles/PMC3834873/figure/f2-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-ijo-43-06-1824" rid-ob="ob-f2-ijo-43-06-1824" co-legend-rid="lgnd_f2-ijo-43-06-1824"><span>Fig. 2A, right panel</span></a>). At 24 h, significant effects were observed at the highest HSP990 dose tested (100 nM; reduction of metabolic activity to &#x0223c;75% compared to controls, p&#x0003c;0.05). At 72 h, significant effects were observed at a HSP990 concentration as low as 5 nM (reduction of metabolic activity to &#x0223c;71%, p&#x0003c;0.05) with a maximum effect at 100 nM (reduction of metabolic activity to &#x0223c;21%, p&#x0003c;0.05). At 144 h, 5 nM HSP990 suppressed BON1 cell metabolic activity to &#x0223c;66% (p&#x0003c;0.05), 10 nM to &#x0223c;52% (p&#x0003c;0.05), 50 nM to &#x0223c;7% (p&#x0003c;0.05) and 100 nM to &#x0223c;3% (p&#x0003c;0.05). For all concentrations and time points the decrease of metabolic activity (<a href="/pmc/articles/PMC3834873/figure/f2-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-ijo-43-06-1824" rid-ob="ob-f2-ijo-43-06-1824" co-legend-rid="lgnd_f2-ijo-43-06-1824"><span>Fig. 2A, upper panels</span></a>) correlated with the decrease of DNA content (<a href="/pmc/articles/PMC3834873/figure/f2-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-ijo-43-06-1824" rid-ob="ob-f2-ijo-43-06-1824" co-legend-rid="lgnd_f2-ijo-43-06-1824"><span>Fig. 2A, lower panels</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f2-ijo-43-06-1824" co-legend-rid="lgnd_f2-ijo-43-06-1824"><a href="/pmc/articles/PMC3834873/figure/f2-ijo-43-06-1824/" target="figure" rid-figpopup="f2-ijo-43-06-1824" rid-ob="ob-f2-ijo-43-06-1824"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140547748422944"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3834873_IJO-43-06-1824-g01.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-43-06-1824-g01.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3834873/bin/IJO-43-06-1824-g01.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140547748422944"><a target="object" rel="noopener" href="/pmc/articles/PMC3834873/figure/f2-ijo-43-06-1824/?report=objectonly">Open in a separate window</a></div><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140547753147328"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3834873_IJO-43-06-1824-g02.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-43-06-1824-g02.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3834873/bin/IJO-43-06-1824-g02.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140547753147328"><a target="object" rel="noopener" href="/pmc/articles/PMC3834873/figure/f2-ijo-43-06-1824/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f2-ijo-43-06-1824"><div><a class="figpopup" href="/pmc/articles/PMC3834873/figure/f2-ijo-43-06-1824/" target="figure" rid-figpopup="f2-ijo-43-06-1824" rid-ob="ob-f2-ijo-43-06-1824">Figure 2.</a></div><!--caption a7--><div class="caption"><p>Time- and dose-dependent effects of HSP90 inhibition on neuroendocrine cell viability. (A) BON1, (B) NCI-H727 and (C) GOT1 cells were treated with increasing concentrations (0.1&#x02013;100 nM) of the HSP90 inhibitor AUY922 or HSP990 for indicated time points (24&#x02013;144 h). Cell viability based on metabolic activity was measured with Cell Titer 96 kit (Promega; upper panels). Cell proliferation based on DNA content was determined by fluorescence SYBR-Green DNA labelling (lower panels). The mean values &#x000b1; SD of 3 independently performed experiments in sextuplicates (n=18) are demonstrated. <sup>*</sup>p&#x0003c;0.05 versus untreated control.</p></div></div></div><p>Treatment of human bronchopulmonary neuroendocrine NCI-H727 tumor cells with AUY922 also suppressed cell viability in a dose-dependent manner (<a href="/pmc/articles/PMC3834873/figure/f2-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-ijo-43-06-1824" rid-ob="ob-f2-ijo-43-06-1824" co-legend-rid="lgnd_f2-ijo-43-06-1824"><span>Fig. 2B, left panel</span></a>). Significant effects were observed at all times points, beginning at a treatment concentration of 5 nM and peaking at the highest concentration tested. Similar to the observed effects of AUY922, treatment with HSP990 dose-dependently suppressed NCI-H727 cell viability (<a href="/pmc/articles/PMC3834873/figure/f2-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-ijo-43-06-1824" rid-ob="ob-f2-ijo-43-06-1824" co-legend-rid="lgnd_f2-ijo-43-06-1824"><span>Fig. 2B, right panel</span></a>). Significant effects were observed at 24, 72 and 144 h with HSP990 concentrations as low as 10 nM.</p><p>Due to their slow growth rate, cell proliferation experiments with human midgut carcinoid GOT1 cells were performed for 72 and 144 h. Treatment with AUY922 dose-dependently suppressed GOT1 cell viability. Significant effects at both time points were observed with AUY922 concentrations as low as 5 nM and peaked at the highest dose tested (100 nM; <a href="/pmc/articles/PMC3834873/figure/f2-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-ijo-43-06-1824" rid-ob="ob-f2-ijo-43-06-1824" co-legend-rid="lgnd_f2-ijo-43-06-1824"><span>Fig. 2C, left panel</span></a>). HSP990 also suppressed GOT1 cell viability with a similar potency (<a href="/pmc/articles/PMC3834873/figure/f2-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-ijo-43-06-1824" rid-ob="ob-f2-ijo-43-06-1824" co-legend-rid="lgnd_f2-ijo-43-06-1824"><span>Fig. 2C, right panel</span></a>).</p><p class="p p-last"><a href="/pmc/articles/PMC3834873/table/t1-ijo-43-06-1824/" target="table" class="fig-table-link figpopup" rid-figpopup="t1-ijo-43-06-1824" rid-ob="ob-t1-ijo-43-06-1824" co-legend-rid=""><span>Table I</span></a> summarizes the IC<sub>50</sub> inhibitory values of AUY922 and HSP990 on proliferation of BON1, NCI-H727 and GOT1 cells (based on metabolic activity data determined by Cell Titer 96 aqueous One Solution Proliferation assay). Lowest IC<sub>50</sub> values were observed for AUY922-mediated BON1 and HSP990-mediated GOT1 metabolic activity (at 144 h).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap anchored whole_rhythm" id="t1-ijo-43-06-1824"><h3>Table I.</h3><!--caption a7--><div class="caption"><p>IC<sub>50</sub> values (nM) of AUY922 and HSP990-mediated inhibition of NET cell proliferation at 72 and 144 h.</p></div><div class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" valign="middle" rowspan="2" colspan="1"></th><th colspan="2" align="center" valign="middle" rowspan="1">AUY922
<hr /></th><th colspan="2" align="center" valign="middle" rowspan="1">HSP990
<hr /></th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1">72 h</th><th align="center" valign="middle" rowspan="1" colspan="1">144 h</th><th align="center" valign="middle" rowspan="1" colspan="1">72 h</th><th align="center" valign="middle" rowspan="1" colspan="1">144 h</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">BON1</td><td align="center" valign="top" rowspan="1" colspan="1">4.4</td><td align="center" valign="top" rowspan="1" colspan="1">4.4</td><td align="center" valign="top" rowspan="1" colspan="1">22.1</td><td align="center" valign="top" rowspan="1" colspan="1">11.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NCI-H727</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">4.6</td><td align="center" valign="top" rowspan="1" colspan="1">50.9</td><td align="center" valign="top" rowspan="1" colspan="1">19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GOT1</td><td align="center" valign="top" rowspan="1" colspan="1">30.3</td><td align="center" valign="top" rowspan="1" colspan="1">5.1</td><td align="center" valign="top" rowspan="1" colspan="1">26.2</td><td align="center" valign="top" rowspan="1" colspan="1">9.4</td></tr></tbody></table></div><div class="largeobj-link align_right" id="largeobj_idm140547755262064"><a target="object" rel="noopener" href="/pmc/articles/PMC3834873/table/t1-ijo-43-06-1824/?report=objectonly">Open in a separate window</a></div></div></div><div id="sec-a.l.c.d" class="sec"><h3 id="sec-a.l.c.dtitle">Effect of HSP90 inhibition on cell cycle distribution of neuroendocrine tumor cells</h3><p class="p p-first-last">To further explore mechanisms for the observed inhibition of neuroendocrine tumor cell viability by HSP90 inhibition, we performed cell cycle analysis of BON1, NCI-H727 and GOT1 cells treated for 24 h with AUY922 and HSP990, respectively. BON1 cells responded to AUY922 treatment with a significant reduction of cells in S phase from &#x0223c;10 to &#x0223c;5%, while the number of cells in G2/M phase was dose-dependently increased (at 50 and 100 nM; p&#x0003c;0.001) (<a href="/pmc/articles/PMC3834873/figure/f3-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3-ijo-43-06-1824" rid-ob="ob-f3-ijo-43-06-1824" co-legend-rid="lgnd_f3-ijo-43-06-1824"><span>Fig. 3, left panel</span></a>). HSP990 also decreased the number of BON1 cells in S phase and increased the number of cells in G2/M phase with a similar potency (<a href="/pmc/articles/PMC3834873/figure/f3-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3-ijo-43-06-1824" rid-ob="ob-f3-ijo-43-06-1824" co-legend-rid="lgnd_f3-ijo-43-06-1824"><span>Fig. 3, right panel</span></a>). In contrast, cell cycle phase distribution of NCI-H727 and GOT1 cells was not altered by overnight HSP inhibition (data not shown).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f3-ijo-43-06-1824" co-legend-rid="lgnd_f3-ijo-43-06-1824"><a href="/pmc/articles/PMC3834873/figure/f3-ijo-43-06-1824/" target="figure" rid-figpopup="f3-ijo-43-06-1824" rid-ob="ob-f3-ijo-43-06-1824"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140547758335984"><img loading="lazy" class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-43-06-1824-g03.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-43-06-1824-g03.jpg" src="/pmc/articles/PMC3834873/bin/IJO-43-06-1824-g03.jpg" /></div><div class="largeobj-link align_right" id="largeobj_idm140547758335984"><a target="object" rel="noopener" href="/pmc/articles/PMC3834873/figure/f3-ijo-43-06-1824/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f3-ijo-43-06-1824"><div><a class="figpopup" href="/pmc/articles/PMC3834873/figure/f3-ijo-43-06-1824/" target="figure" rid-figpopup="f3-ijo-43-06-1824" rid-ob="ob-f3-ijo-43-06-1824">Figure 3.</a></div><!--caption a7--><div class="caption"><p>Effect of HSP90 inhibition on cell cycle distribution of neuroendocrine tumor cells. Human pancreatic neuroendocrine BON1 cells cultured in complete medium were treated with the indicated concentrations (1&#x02013;100 nM) of the HSP90 inhibitors AUY922 (left panel) or HSP990 (right panel) for 24 h. Demonstrated are the mean values &#x000b1; SD of 3 independently performed experiments in duplicates (n=6); p&#x0003c;0.001 versus untreated control.</p></div></div></div></div><div id="sec-a.l.c.e" class="sec"><h3 id="sec-a.l.c.etitle">HSP90 inhibition induces apoptosis in neuroendocrine tumor cells</h3><p class="p p-first">Twenty-four hour treatment of BON1 cells with AUY922 dose-dependently increased the number of cells in sub-G1 phase up to &#x0223c;1.7-fold (100 nM, p&#x0003c;0.05; <a href="/pmc/articles/PMC3834873/figure/f4-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-43-06-1824" rid-ob="ob-f4-ijo-43-06-1824" co-legend-rid="lgnd_f4-ijo-43-06-1824"><span>Fig. 4A</span></a>). HSP990 also increased the number of sub-G1 events up to &#x0223c;1.4-fold (100 nM, p&#x0003c;0.05; <a href="/pmc/articles/PMC3834873/figure/f4-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-43-06-1824" rid-ob="ob-f4-ijo-43-06-1824" co-legend-rid="lgnd_f4-ijo-43-06-1824"><span>Fig. 4A</span></a>). Furthermore, AUY922 and HSP990 treatment resulted in a significant increase of NCI-H727 cells in sub-G1 phase up to &#x0223c;1.6-fold (100 nM AUY922, p&#x0003c;0.05; <a href="/pmc/articles/PMC3834873/figure/f4-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-43-06-1824" rid-ob="ob-f4-ijo-43-06-1824" co-legend-rid="lgnd_f4-ijo-43-06-1824"><span>Fig. 4A</span></a>) and &#x0223c;1.3-fold (100 nM HSP990, p&#x0003c;0.05; <a href="/pmc/articles/PMC3834873/figure/f4-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-43-06-1824" rid-ob="ob-f4-ijo-43-06-1824" co-legend-rid="lgnd_f4-ijo-43-06-1824"><span>Fig. 4A</span></a>), respectively. GOT1 cells showed the strongest increase of DNA fragmentation in response to HSP90 inhibition (up to &#x0223c;2.5-fold at 100 nM AUY922 or HSP990, p&#x0003c;0.05; <a href="/pmc/articles/PMC3834873/figure/f4-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-43-06-1824" rid-ob="ob-f4-ijo-43-06-1824" co-legend-rid="lgnd_f4-ijo-43-06-1824"><span>Fig. 4A</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f4-ijo-43-06-1824" co-legend-rid="lgnd_f4-ijo-43-06-1824"><a href="/pmc/articles/PMC3834873/figure/f4-ijo-43-06-1824/" target="figure" rid-figpopup="f4-ijo-43-06-1824" rid-ob="ob-f4-ijo-43-06-1824"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140547753808608"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3834873_IJO-43-06-1824-g04.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-43-06-1824-g04.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3834873/bin/IJO-43-06-1824-g04.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140547753808608"><a target="object" rel="noopener" href="/pmc/articles/PMC3834873/figure/f4-ijo-43-06-1824/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f4-ijo-43-06-1824"><div><a class="figpopup" href="/pmc/articles/PMC3834873/figure/f4-ijo-43-06-1824/" target="figure" rid-figpopup="f4-ijo-43-06-1824" rid-ob="ob-f4-ijo-43-06-1824">Figure 4.</a></div><!--caption a7--><div class="caption"><p>HSP90 inhibition induces apoptosis in neuroendocrine tumor cells. (A and B) BON1, NCI-H727 and GOT1 cells were treated with increasing concentrations (1&#x02013;100 nM) of AUY922 or HSP990. After 24 h the proportion of cells in subG1 phase was examined by flow cytometry (A; duplicates, n=6). Additionally, cells were treated with 100 nM of AUY922 or HSP990 and TRAIL (10 ng/ml) as a positive control. After 24 h the activity of effector caspases 3 and 7 was measured with Caspase-Glo 3/7 assay (B; singular values, n=3). Shown are the mean values &#x000b1; SD of three independently performed experiments. <sup>*</sup>p&#x0003c;0.05 versus untreated control. (C) BON1, NCI-H727 and GOT1 cells were treated with increasing concentrations (1&#x02013;100 nM) of AUY922 or HSP990. (C) After 24 h the extent of PARP cleavage was determined by western blot analysis.</p></div></div></div><p class="p p-last">To further specify the observed HSP90 inhibition-mediated increase of the sub-G1 fraction, cells were additionally assayed for the activity of effector caspases 3 and 7. While inducing only slight increases of caspase 3/7 activity in BON1 and NCI-H727 cells, both HSP90 inhibitors induced a massive increase of caspase 3/7 activity in GOT1 cells up to &#x0223c;7.0-fold (100 nM AUY922, p&#x0003c;0.05; <a href="/pmc/articles/PMC3834873/figure/f4-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-43-06-1824" rid-ob="ob-f4-ijo-43-06-1824" co-legend-rid="lgnd_f4-ijo-43-06-1824"><span>Fig. 4B</span></a>). The induction of PARP cleavage confirmed the results obtained by measurement of caspase 3/7 activity, demonstrating more potent induction of PARP cleavage in GOT1 compared to BON1 and NCI-H727 cells (<a href="/pmc/articles/PMC3834873/figure/f4-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f4-ijo-43-06-1824" rid-ob="ob-f4-ijo-43-06-1824" co-legend-rid="lgnd_f4-ijo-43-06-1824"><span>Fig. 4C</span></a>).</p></div><div id="sec-a.l.c.f" class="sec sec-last"><h3 id="sec-a.l.c.ftitle">Mechanisms for HSP90 inhibition in neuroendocrine tumor cells: effects on downstream signaling</h3><p class="p p-first">As the HSP90 inhibitor 17-AAG has recently been reported to reduce EGFR and IGF-IR expression in the bronchopulmonary typical carcinoid cell line NCI-H727 (<a href="#b13-ijo-43-06-1824" rid="b13-ijo-43-06-1824" class=" bibr popnode">13</a>,<a href="#b15-ijo-43-06-1824" rid="b15-ijo-43-06-1824" class=" bibr popnode">15</a>), we examined the effect of AUY922 and HSP990 on ErbB and IGF-I receptor expression. Treatment of BON1 cells with AUY922 and HSP990 for 24 h suppressed both ErbB2 and EGF receptor expression starting at concentrations of 5 to 10 nM with minor inhibitory effects observed on ErbB3 expression (<a href="/pmc/articles/PMC3834873/figure/f5-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5-ijo-43-06-1824" rid-ob="ob-f5-ijo-43-06-1824" co-legend-rid="lgnd_f5-ijo-43-06-1824"><span>Fig. 5</span></a>). In addition, strong inhibitory effects were observed on IGF-I receptor expression (<a href="/pmc/articles/PMC3834873/figure/f5-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5-ijo-43-06-1824" rid-ob="ob-f5-ijo-43-06-1824" co-legend-rid="lgnd_f5-ijo-43-06-1824"><span>Fig. 5</span></a>). In NCI-H727 cells, HSP90 inhibition abolished ErbB2 and IGF-I receptor expression, while inhibitory effects were observed on ErbB3 and EGF receptor expression (<a href="/pmc/articles/PMC3834873/figure/f5-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5-ijo-43-06-1824" rid-ob="ob-f5-ijo-43-06-1824" co-legend-rid="lgnd_f5-ijo-43-06-1824"><span>Fig. 5</span></a>). In contrast to BON1 and NCI-H727 cells, ErbB2, ErbB3 and IGF-I receptor are not detectable in GOT1 cells. However, treatment of GOT1 cells with AUY922 and HSP990 for 24 h strongly suppressed EGF receptor expression (<a href="/pmc/articles/PMC3834873/figure/f5-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f5-ijo-43-06-1824" rid-ob="ob-f5-ijo-43-06-1824" co-legend-rid="lgnd_f5-ijo-43-06-1824"><span>Fig. 5</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f5-ijo-43-06-1824" co-legend-rid="lgnd_f5-ijo-43-06-1824"><a href="/pmc/articles/PMC3834873/figure/f5-ijo-43-06-1824/" target="figure" rid-figpopup="f5-ijo-43-06-1824" rid-ob="ob-f5-ijo-43-06-1824"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140547751693536"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3834873_IJO-43-06-1824-g05.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-43-06-1824-g05.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3834873/bin/IJO-43-06-1824-g05.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140547751693536"><a target="object" rel="noopener" href="/pmc/articles/PMC3834873/figure/f5-ijo-43-06-1824/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f5-ijo-43-06-1824"><div><a class="figpopup" href="/pmc/articles/PMC3834873/figure/f5-ijo-43-06-1824/" target="figure" rid-figpopup="f5-ijo-43-06-1824" rid-ob="ob-f5-ijo-43-06-1824">Figure 5.</a></div><!--caption a7--><div class="caption"><p>Effect of HSP90 inhibition on RTK expression in neuroendocrine BON1 tumor cells. BON1, NCI-H727 and GOT1 cells were treated with increasing concentrations (1&#x02013;100 nM) of the HSP90 inhibitor AUY922 (left panel) or HSP990 (right panel) for 24 h. Subsequently the expression of EGFR, ErbB2, ErbB3 and IGFIR was evaluated by western blot analysis. A representative blot out of 3 independently performed experiments is shown.</p></div></div></div><p class="p p-last">Untreated BON1, NCI-H727 and GOT1 cells cultured in complete medium, exhibited baseline activation of Akt and Erk signaling pathways (<a href="/pmc/articles/PMC3834873/figure/f6-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f6-ijo-43-06-1824" rid-ob="ob-f6-ijo-43-06-1824" co-legend-rid="lgnd_f6-ijo-43-06-1824"><span>Fig. 6</span></a>). Treatment of all cells with AUY922 and HSP990 dose-dependently suppressed Erk, Akt, p70S6K and 4EBP1 phosphorylation (<a href="/pmc/articles/PMC3834873/figure/f6-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f6-ijo-43-06-1824" rid-ob="ob-f6-ijo-43-06-1824" co-legend-rid="lgnd_f6-ijo-43-06-1824"><span>Fig. 6</span></a>). Potent inhibition on PI3K/Akt signaling was also demonstrated by suppression of Akt and p70S6K protein expression. Total Erk and &#x003b2;-actin protein expression remained unaffected at all concentrations tested (<a href="/pmc/articles/PMC3834873/figure/f6-ijo-43-06-1824/" target="figure" class="fig-table-link figpopup" rid-figpopup="f6-ijo-43-06-1824" rid-ob="ob-f6-ijo-43-06-1824" co-legend-rid="lgnd_f6-ijo-43-06-1824"><span>Fig. 6</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="f6-ijo-43-06-1824" co-legend-rid="lgnd_f6-ijo-43-06-1824"><a href="/pmc/articles/PMC3834873/figure/f6-ijo-43-06-1824/" target="figure" rid-figpopup="f6-ijo-43-06-1824" rid-ob="ob-f6-ijo-43-06-1824"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm140547749123888"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3834873_IJO-43-06-1824-g06.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is IJO-43-06-1824-g06.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3834873/bin/IJO-43-06-1824-g06.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm140547749123888"><a target="object" rel="noopener" href="/pmc/articles/PMC3834873/figure/f6-ijo-43-06-1824/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_f6-ijo-43-06-1824"><div><a class="figpopup" href="/pmc/articles/PMC3834873/figure/f6-ijo-43-06-1824/" target="figure" rid-figpopup="f6-ijo-43-06-1824" rid-ob="ob-f6-ijo-43-06-1824">Figure 6.</a></div><!--caption a7--><div class="caption"><p>Effect of HSP90 inhibition on downstream signaling. BON1, NCI-H727 and GOT1 cells were treated with increasing concentrations (1&#x02013;100 nM) of the HSP90 inhibitor AUY922 (left panel) or HSP990 (right panel) for 24 h. Subsequently, the expression of pErk1/2, Erk1/2, pAkt, Akt, pp70S6K, p70S6K, p4EBP1 and 4EBP1 was evaluated by western blot analysis. A representative blot out of 3 independently performed experiments is shown.</p></div></div></div></div></div><div id="sec-a.l.d" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.l.dtitle">Discussion</h2><p class="p p-first">Due to increased incidence and relatively poor prognosis of GEP-NETs alternative treatment options are required for this heterogeneous group of tumors (<a href="#b5-ijo-43-06-1824" rid="b5-ijo-43-06-1824" class=" bibr popnode">5</a>,<a href="#b6-ijo-43-06-1824" rid="b6-ijo-43-06-1824" class=" bibr popnode">6</a>,<a href="#b9-ijo-43-06-1824" rid="b9-ijo-43-06-1824" class=" bibr popnode">9</a>). High Akt and Erk activity in NETs as well as compensatory Akt activation in response to mTOR and Raf inhibitors, suggest that simultaneous blockade of multiple oncogenic neuroendocrine signaling cascades could be a more effective therapeutic approach (<a href="#b10-ijo-43-06-1824" rid="b10-ijo-43-06-1824" class=" bibr popnode">10</a>,<a href="#b11-ijo-43-06-1824" rid="b11-ijo-43-06-1824" class=" bibr popnode">11</a>). As HSP90 is overexpressed in NETs and controls the function of multiple oncogenic proteins (<a href="#b2-ijo-43-06-1824" rid="b2-ijo-43-06-1824" class=" bibr popnode">2</a>,<a href="#b13-ijo-43-06-1824" rid="b13-ijo-43-06-1824" class=" bibr popnode">13</a>), we examined the effect of HSP90 inhibition on neuroendocrine cell proliferation and signaling.</p><p>HSP90 inhibition was performed with novel low molecular weight ATP-competitive non-geldamycin HSP90 inhibitors AUY922 and the novel oral inhibitor HSP990. These compounds have been speculated to offer advantages over ansamycin benzoquinone HSP90 inhibitors such as 17-allylamino-17-demethoxygeldanamycin (17-AAG) based on the independence from NAD(P)H:quinone oxidoreductase 1 (NQO1) metabolism, P-glycoprotein expression and favorable aqueous solubility (<a href="#b16-ijo-43-06-1824" rid="b16-ijo-43-06-1824" class=" bibr popnode">16</a>,<a href="#b17-ijo-43-06-1824" rid="b17-ijo-43-06-1824" class=" bibr popnode">17</a>). All three compounds are currently in clinical trials in different solid tumor entities.</p><p>Treatment of human pancreatic BON1, bronchopulmonary NCI-H727 and midgut GOT1 carcinoid cells with increasing concentrations of AUY922 and HSP990 dose-dependently decreased cell viability. Recently, also the HSP90 inhibitors 17-AAG and IPI504 have been reported to inhibit cell viability in NCI-H727 cells with an IC<sub>50</sub> value of 70.4 and 192 nM, respectively (<a href="#b12-ijo-43-06-1824" rid="b12-ijo-43-06-1824" class=" bibr popnode">12</a>,<a href="#b13-ijo-43-06-1824" rid="b13-ijo-43-06-1824" class=" bibr popnode">13</a>). In the current study, significant inhibition of cell viability was observed with inhibitor concentrations as low as 5 nM particularly after prolonged treatment (72&#x02013;144 h). Inhibition of neuroendocrine cell viability was associated with the induction of apoptosis (especially in GOT1 cells) as demonstrated by increased number of sub-G1 events, as well as the induction of caspase 3/7 and PARP cleavage. Consistently, AUY922 has recently been demonstrated to induce apoptosis in multiple myeloma and glioblastoma cell lines (<a href="#b18-ijo-43-06-1824" rid="b18-ijo-43-06-1824" class=" bibr popnode">18</a>,<a href="#b19-ijo-43-06-1824" rid="b19-ijo-43-06-1824" class=" bibr popnode">19</a>).</p><p>In addition to apoptosis induction, HSP90 inhibition in human pancreatic BON1 cells was also associated with a pronounced increase of cells in G2/M phase, while no effect on cell cycle distribution was observed in NCI-H727 and GOT1 cells. Induction of apoptosis combined with inhibition of cell cycle progression (arrest in G2M phase) could explain the more potent inhibition of cell viability in BON1 compared to NCI-H727 cells. However, different growth rates of the cell lines tested may also have an impact on cell cycle analysis of non-synchronized cells at a given time point (overnight treatment).</p><p>In addition to HSP90, members of the ErbB receptor family EGFR and ErbB2, as well as IGF-IR are also expressed in NETs and could present alternative treatment targets (<a href="#b13-ijo-43-06-1824" rid="b13-ijo-43-06-1824" class=" bibr popnode">13</a>,<a href="#b20-ijo-43-06-1824" rid="b20-ijo-43-06-1824" class=" bibr popnode">20</a>). Here we show AUY922 and HSP90-mediated inhibition of ErbB receptor (EGFR, ErbB2 and ErbB3), and IGF-I receptor expression in BON1 and NCI-H727 cells, likely as a result of dissociation from HSP90 and subsequent increase in ubiquitinylation and proteosomal degradation (<a href="#b1-ijo-43-06-1824" rid="b1-ijo-43-06-1824" class=" bibr popnode">1</a>). NETs are characterized by high activity of Erk and Akt signalling (<a href="#b10-ijo-43-06-1824" rid="b10-ijo-43-06-1824" class=" bibr popnode">10</a>). Consistently, we detected baseline activity of Erk and Akt signalling pathways (phosphorylation of Erk, Akt, p70S6K, 4EBP1) in all NET cell lines tested. Neuroendocrine HSP90 inhibition suppressed both signalling pathways, possibly at least in part through depletion of upstream signalling RTKs. Interestingly, HSP90 inhibitors at lower concentrations (5&#x02013;10 nM) increased p70S6K and 4EBP1 signalling in BON1 cells possibly due to incomplete HSP90 inhibition at this concentration and compensatory activation of alternate stimulatory feedback. HSP90 inhibition was not a toxic effect, since no effect was observed on Erk, or &#x003b2;-actin expression. Furthermore, HSP90 inhibition was associated with HSP70 upregulation, a hallmark of HSP90 inhibition.</p><p class="p p-last">Considering the complexity of neuroendocrine tumors, targeting a single pathway by inhibiting the activity of one component is unlikely to be effective in the long term due to development of resistance and activation of compensatory mechanisms (<a href="#b11-ijo-43-06-1824" rid="b11-ijo-43-06-1824" class=" bibr popnode">11</a>). We report simultaneous suppression of neuroendocrine Erk and Akt signalling associated with induction of apoptosis and inhibition of cell viability by the novel HSP90 inhibitors AUY922 and HSP990. As HSP90 overexpression was recently reported in NETs (<a href="#b13-ijo-43-06-1824" rid="b13-ijo-43-06-1824" class=" bibr popnode">13</a>) inhibition of HSP90 alone or in combination with other molecular targets could be useful for the treatment of aggressive neuroendocrine tumors resistant to conventional therapy. Further preclinical and clinical studies are needed to evaluate the potential role of HSP90 inhibitors in neuroendocrine tumors.</p></div><div id="ack-a.m.a" class="tsec sec"><h2 class="head no_bottom_margin" id="ack-a.m.atitle">Acknowledgments</h2><div class="sec"><p>C.J.A. has received research contracts, lecture honorarium and advisory board honorarium from Novartis. F.B. has received research contracts from Novartis. This study contains parts of the unpublished doctoral theses of G. Ailer. This study has been supported in part by a grant from the German Federal Ministry of Education and Research [01EX1021B, Spitzencluster M4, Verbund Personalisierte Medizin: Teilprojekt NeoExNET (PM1)] to C.J.A. and F.B. and a restricted research grant from Novartis Oncology Germany to C.J.A.</p></div></div><div id="ref-list-a.m.b" class="tsec sec"><h2 class="head no_bottom_margin" id="ref-list-a.m.btitle">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="b1-ijo-43-06-1824">1. <span class="element-citation">Peterson LB, Blagg BS. To fold or not to fold: modulation and consequences of Hsp90 inhibition. <span><span class="ref-journal">Future Med Chem. </span>2009;<span class="ref-vol">1</span>:267–283.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2784693/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20161407" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Future+Med+Chem&amp;title=To+fold+or+not+to+fold:+modulation+and+consequences+of+Hsp90+inhibition&amp;author=LB+Peterson&amp;author=BS+Blagg&amp;volume=1&amp;publication_year=2009&amp;pages=267-283&amp;pmid=20161407&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b2-ijo-43-06-1824">2. <span class="element-citation">Trepel J, Mollapour M, Giaccone G, Neckers L. Targeting the dynamic HSP90 complex in cancer. <span><span class="ref-journal">Nat Rev Cancer. </span>2010;<span class="ref-vol">10</span>:537–549.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6778733/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20651736" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Cancer&amp;title=Targeting+the+dynamic+HSP90+complex+in+cancer&amp;author=J+Trepel&amp;author=M+Mollapour&amp;author=G+Giaccone&amp;author=L+Neckers&amp;volume=10&amp;publication_year=2010&amp;pages=537-549&amp;pmid=20651736&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b3-ijo-43-06-1824">3. <span class="element-citation">Porter JR, Fritz CC, Depew KM. Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy. <span><span class="ref-journal">Curr Opin Chem Biol. </span>2010;<span class="ref-vol">14</span>:412–420.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20409745" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Opin+Chem+Biol&amp;title=Discovery+and+development+of+Hsp90+inhibitors:+a+promising+pathway+for+cancer+therapy&amp;author=JR+Porter&amp;author=CC+Fritz&amp;author=KM+Depew&amp;volume=14&amp;publication_year=2010&amp;pages=412-420&amp;pmid=20409745&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b4-ijo-43-06-1824">4. <span class="element-citation">Kim YS, Alarcon SV, Lee S, Lee MJ, Giaccone G, Neckers L, Trepel JB. Update on Hsp90 inhibitors in clinical trial. <span><span class="ref-journal">Curr Top Med Chem. </span>2009;<span class="ref-vol">9</span>:1479–1492.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7241864/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19860730" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Top+Med+Chem&amp;title=Update+on+Hsp90+inhibitors+in+clinical+trial&amp;author=YS+Kim&amp;author=SV+Alarcon&amp;author=S+Lee&amp;author=MJ+Lee&amp;author=G+Giaccone&amp;volume=9&amp;publication_year=2009&amp;pages=1479-1492&amp;pmid=19860730&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b5-ijo-43-06-1824">5. <span class="element-citation">Massironi S, Sciola V, Peracchi M, Ciafardini C, Spampatti MP, Conte D. Neuroendocrine tumors of the gastro-enteropancreatic system. <span><span class="ref-journal">World J Gastroenterol. </span>2008;<span class="ref-vol">14</span>:5377–5384.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2744160/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18803349" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+J+Gastroenterol&amp;title=Neuroendocrine+tumors+of+the+gastro-enteropancreatic+system&amp;author=S+Massironi&amp;author=V+Sciola&amp;author=M+Peracchi&amp;author=C+Ciafardini&amp;author=MP+Spampatti&amp;volume=14&amp;publication_year=2008&amp;pages=5377-5384&amp;pmid=18803349&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b6-ijo-43-06-1824">6. <span class="element-citation">Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A. Gastroenteropancreatic neuroendocrine tumours. <span><span class="ref-journal">Lancet Oncol. </span>2008;<span class="ref-vol">9</span>:61–72.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18177818" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Oncol&amp;title=Gastroenteropancreatic+neuroendocrine+tumours&amp;author=IM+Modlin&amp;author=K+Oberg&amp;author=DC+Chung&amp;author=RT+Jensen&amp;author=WW+de+Herder&amp;volume=9&amp;publication_year=2008&amp;pages=61-72&amp;pmid=18177818&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b7-ijo-43-06-1824">7. <span class="element-citation">Janson ET, S&#x000f8;rbye H, Welin S, Federspiel B, Gr&#x000f8;nbaek H, Hellman P, Mathisen O, Mortensen J, Sundin A, Thiis-Evensen E, V&#x000e4;lim&#x000e4;ki MJ, Oberg K, Knigge U. Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. <span><span class="ref-journal">Acta Oncol. </span>2010;<span class="ref-vol">49</span>:740–756.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20553100" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Oncol&amp;title=Nordic+Guidelines+2010+for+diagnosis+and+treatment+of+gastroenteropancreatic+neuroendocrine+tumours&amp;author=ET+Janson&amp;author=H+S&#x000f8;rbye&amp;author=S+Welin&amp;author=B+Federspiel&amp;author=H+Gr&#x000f8;nbaek&amp;volume=49&amp;publication_year=2010&amp;pages=740-756&amp;pmid=20553100&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b8-ijo-43-06-1824">8. <span class="element-citation">Auernhammer CJ, G&#x000f6;ke B. Therapeutic strategies for advanced neuroendocrine carcinomas of jejunum/ileum and pancreatic origin. <span><span class="ref-journal">Gut. </span>2011;<span class="ref-vol">60</span>:1009–1021.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21378384" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Therapeutic+strategies+for+advanced+neuroendocrine+carcinomas+of+jejunum/ileum+and+pancreatic+origin&amp;author=CJ+Auernhammer&amp;author=B+G&#x000f6;ke&amp;volume=60&amp;publication_year=2011&amp;pages=1009-1021&amp;pmid=21378384&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b9-ijo-43-06-1824">9. <span class="element-citation">Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. One hundred years after &#x02018;carcinoid&#x02019;: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. <span><span class="ref-journal">J Clin Oncol. </span>2008;<span class="ref-vol">26</span>:3063–3072.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18565894" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=One+hundred+years+after+&#x02018;carcinoid&#x02019;:+epidemiology+of+and+prognostic+factors+for+neuroendocrine+tumors+in+35,825+cases+in+the+United+States&amp;author=JC+Yao&amp;author=M+Hassan&amp;author=A+Phan&amp;author=C+Dagohoy&amp;author=C+Leary&amp;volume=26&amp;publication_year=2008&amp;pages=3063-3072&amp;pmid=18565894&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b10-ijo-43-06-1824">10. <span class="element-citation">Shah T, Hochhauser D, Frow R, Quaglia A, Dhillon AP, Caplin ME. Epidermal growth factor receptor expression and activation in neuroendocrine tumours. <span><span class="ref-journal">J Neuroendocrinol. </span>2006;<span class="ref-vol">18</span>:355–360.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16629834" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroendocrinol&amp;title=Epidermal+growth+factor+receptor+expression+and+activation+in+neuroendocrine+tumours&amp;author=T+Shah&amp;author=D+Hochhauser&amp;author=R+Frow&amp;author=A+Quaglia&amp;author=AP+Dhillon&amp;volume=18&amp;publication_year=2006&amp;pages=355-360&amp;pmid=16629834&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b11-ijo-43-06-1824">11. <span class="element-citation">Zitzmann K, R&#x000fc;den Jv, Brand S, G&#x000f6;ke B, Lichtl J, Sp&#x000f6;ttl G, Auernhammer CJ. Compensatory activation of Akt in response to mTOR and Raf inhibitors - a rationale for dual-targeted therapy approaches in neuroendocrine tumor disease. <span><span class="ref-journal">Cancer Lett. </span>2010;<span class="ref-vol">295</span>:100–109.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20356670" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Lett&amp;title=Compensatory+activation+of+Akt+in+response+to+mTOR+and+Raf+inhibitors+-+a+rationale+for+dual-targeted+therapy+approaches+in+neuroendocrine+tumor+disease&amp;author=K+Zitzmann&amp;author=Jv+R&#x000fc;den&amp;author=S+Brand&amp;author=B+G&#x000f6;ke&amp;author=J+Lichtl&amp;volume=295&amp;publication_year=2010&amp;pages=100-109&amp;pmid=20356670&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b12-ijo-43-06-1824">12. <span class="element-citation">Gloesenkamp C, Nitzsche B, Lim AR, Normant E, Vosburgh E, Schrader M, Ocker M, Scher&#x000fc;bl H, H&#x000f6;pfner M. Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors. <span><span class="ref-journal">Int J Oncol. </span>2012;<span class="ref-vol">40</span>:1659–1667.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22246317" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Oncol&amp;title=Heat+shock+protein+90+is+a+promising+target+for+effective+growth+inhibition+of+gastrointestinal+neuroendocrine+tumors&amp;author=C+Gloesenkamp&amp;author=B+Nitzsche&amp;author=AR+Lim&amp;author=E+Normant&amp;author=E+Vosburgh&amp;volume=40&amp;publication_year=2012&amp;pages=1659-1667&amp;pmid=22246317&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b13-ijo-43-06-1824">13. <span class="element-citation">Gilbert JA, Adhikari LJ, Lloyd RV, Rubin J, Haluska P, Carboni JM, Gottardis MM, Ames MM. Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors. <span><span class="ref-journal">Endocr Relat Cancer. </span>2010;<span class="ref-vol">17</span>:623–636.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20385747" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Relat+Cancer&amp;title=Molecular+markers+for+novel+therapies+in+neuroendocrine+(carcinoid)+tumors&amp;author=JA+Gilbert&amp;author=LJ+Adhikari&amp;author=RV+Lloyd&amp;author=J+Rubin&amp;author=P+Haluska&amp;volume=17&amp;publication_year=2010&amp;pages=623-636&amp;pmid=20385747&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b14-ijo-43-06-1824">14. <span class="element-citation">Zitzmann K, de Toni E, von R&#x000fc;den J, Brand S, G&#x000f6;ke B, Laubender RP, Auernhammer CJ. The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells. <span><span class="ref-journal">Endocr Relat Cancer. </span>2011;<span class="ref-vol">18</span>:277–285.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21317202" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocr+Relat+Cancer&amp;title=The+novel+Raf+inhibitor+Raf265+decreases+Bcl-2+levels+and+confers+TRAIL-sensitivity+to+neuroendocrine+tumour+cells&amp;author=K+Zitzmann&amp;author=E+de+Toni&amp;author=J+von+R&#x000fc;den&amp;author=S+Brand&amp;author=B+G&#x000f6;ke&amp;volume=18&amp;publication_year=2011&amp;pages=277-285&amp;pmid=21317202&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b15-ijo-43-06-1824">15. <span class="element-citation">Cakir M, Grossman A. The molecular pathogenesis and management of bronchial carcinoids. <span><span class="ref-journal">Expert Opin Ther Targets. </span>2011;<span class="ref-vol">15</span>:457–491.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21275849" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Expert+Opin+Ther+Targets&amp;title=The+molecular+pathogenesis+and+management+of+bronchial+carcinoids&amp;author=M+Cakir&amp;author=A+Grossman&amp;volume=15&amp;publication_year=2011&amp;pages=457-491&amp;pmid=21275849&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b16-ijo-43-06-1824">16. <span class="element-citation">Eccles SA, Massey A, Raynaud FI, Sharp SY, Box G, Valenti M, Patterson L, de Haven Brandon A, Gowan S, Boxall F, Aherne W, Rowlands M, Hayes A, Martins V, Urban F, Boxall K, Prodromou C, Pearl L, James K, Matthews TP, Cheung KM, Kalusa A, Jones K, McDonald E, Barril X, Brough PA, Cansfield JE, Dymock B, Drysdale MJ, Finch H, Howes R, Hubbard RE, Surgenor A, Webb P, Wood M, Wright L, Workman P. NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis. <span><span class="ref-journal">Cancer Res. </span>2008;<span class="ref-vol">68</span>:2850–2860.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18413753" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=NVP-AUY922:+a+novel+heat+shock+protein+90+inhibitor+active+against+xenograft+tumor+growth,+angiogenesis,+and+metastasis&amp;author=SA+Eccles&amp;author=A+Massey&amp;author=FI+Raynaud&amp;author=SY+Sharp&amp;author=G+Box&amp;volume=68&amp;publication_year=2008&amp;pages=2850-2860&amp;pmid=18413753&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b17-ijo-43-06-1824">17. <span class="element-citation">Sharp SY, Prodromou C, Boxall K, Powers MV, Holmes JL, Box G, Matthews TP, Cheung KM, Kalusa A, James K, Hayes A, Hardcastle A, Dymock B, Brough PA, Barril X, Cansfield JE, Wright L, Surgenor A, Foloppe N, Hubbard RE, Aherne W, Pearl L, Jones K, McDonald E, Raynaud F, Eccles S, Drysdale M, Workman P. Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues. <span><span class="ref-journal">Mol Cancer Ther. </span>2007;<span class="ref-vol">6</span>:1198–1211.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17431102" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer+Ther&amp;title=Inhibition+of+the+heat+shock+protein+90+molecular+chaperone+in+vitro+and+in+vivo+by+novel,+synthetic,+potent+resorcinylic+pyrazole/isoxazole+amide+analogues&amp;author=SY+Sharp&amp;author=C+Prodromou&amp;author=K+Boxall&amp;author=MV+Powers&amp;author=JL+Holmes&amp;volume=6&amp;publication_year=2007&amp;pages=1198-1211&amp;pmid=17431102&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b18-ijo-43-06-1824">18. <span class="element-citation">Gaspar N, Sharp SY, Eccles SA, Gowan S, Popov S, Jones C, Pearson A, Vassal G, Workman P. Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastoma. <span><span class="ref-journal">Mol Cancer Ther. </span>2010;<span class="ref-vol">9</span>:1219–1233.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2875164/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20457619" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Cancer+Ther&amp;title=Mechanistic+evaluation+of+the+novel+HSP90+inhibitor+NVP-AUY922+in+adult+and+pediatric+glioblastoma&amp;author=N+Gaspar&amp;author=SY+Sharp&amp;author=SA+Eccles&amp;author=S+Gowan&amp;author=S+Popov&amp;volume=9&amp;publication_year=2010&amp;pages=1219-1233&amp;pmid=20457619&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b19-ijo-43-06-1824">19. <span class="element-citation">St&#x000fc;hmer T, Z&#x000f6;llinger A, Siegmund D, Chatterjee M, Grella E, Knop S, Kort&#x000fc;m M, Unzicker C, Jensen MR, Quadt C, Ch&#x000e8;ne P, Schoepfer J, Garc&#x000ed;a-Echeverr&#x000ed;a C, Einsele H, Wajant H, Bargou RC. Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma. <span><span class="ref-journal">Leukemia. </span>2008;<span class="ref-vol">22</span>:1604–1612.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18480838" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Signalling+profile+and+antitumour+activity+of+the+novel+Hsp90+inhibitor+NVP-AUY922+in+multiple+myeloma&amp;author=T+St&#x000fc;hmer&amp;author=A+Z&#x000f6;llinger&amp;author=D+Siegmund&amp;author=M+Chatterjee&amp;author=E+Grella&amp;volume=22&amp;publication_year=2008&amp;pages=1604-1612&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b20-ijo-43-06-1824">20. <span class="element-citation">Papouchado B, Erickson LA, Rohlinger AL, Hobday TJ, Erlichman C, Ames MM, Lloyd RV. Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas. <span><span class="ref-journal">Mod Pathol. </span>2005;<span class="ref-vol">18</span>:1329–1335.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15920550" ref="reftype=pubmed&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mod+Pathol&amp;title=Epidermal+growth+factor+receptor+and+activated+epidermal+growth+factor+receptor+expression+in+gastrointestinal+carcinoids+and+pancreatic+endocrine+carcinomas&amp;author=B+Papouchado&amp;author=LA+Erickson&amp;author=AL+Rohlinger&amp;author=TJ+Hobday&amp;author=C+Erlichman&amp;volume=18&amp;publication_year=2005&amp;pages=1329-1335&amp;pmid=15920550&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=3834873&amp;issue-id=229984&amp;journal-id=1964&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">International Journal of Oncology</span> are provided here courtesy of <strong>Spandidos Publications</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC3834873/pdf/ijo-43-06-1824.pdf" class="int-view">PDF (1.0M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/3834873/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/3834873/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="3834873" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3834873%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="YmRLdIdF9fbEmuo8hxuvWEhBO6tQfOY2ao8clwEGRfOwdmEYvrEDN74hk91IqvJl">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3834873%2F&amp;text=Potent%20antitumor%20activity%20of%20the%20novel%20HSP90%20inhibitors%20AUY922%20and%20HSP990%20in%20neuroendocrine%20carcinoid%20cells" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3834873%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834873/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC3834873/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/24100469/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC3834873/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/24100469/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC3834873/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/3834873/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC3834873/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
